These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Peyronie's disease and systemic lupus erythematosus syndrome associated with metoprolol administration: a case report. Paladini G Int J Tissue React; 1981 Jun; 3(2):95-8. PubMed ID: 7327618 [TBL] [Abstract][Full Text] [Related]
5. Peyronie's disease is associated with Paget's disease of bone. Lyles KW; Gold DT; Newton RA; Parekh S; Shipp KM; Pieper CF; Krishan R; Carson CC J Bone Miner Res; 1997 Jun; 12(6):929-34. PubMed ID: 9169352 [TBL] [Abstract][Full Text] [Related]
6. Peyronie's Disease. Taylor FL; Levine LA Urol Clin North Am; 2007 Nov; 34(4):517-34, vi. PubMed ID: 17983892 [TBL] [Abstract][Full Text] [Related]
7. The treatment of loss of penile rigidity associated with Peyronie's disease. Krane RJ Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682 [TBL] [Abstract][Full Text] [Related]
8. Peyronie's disease following long-term use of topical timolol. Ross JJ; Rahman I; Walters RF Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480 [No Abstract] [Full Text] [Related]
9. [Advances in the research of Peyronie's disease]. Zhao F; Li H Zhonghua Nan Ke Xue; 2004 May; 10(5):378-81. PubMed ID: 15190836 [TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of Peyronie's disease. Carson CC Can J Urol; 2006 Feb; 13 Suppl 1():28-33. PubMed ID: 16526978 [TBL] [Abstract][Full Text] [Related]
11. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease. Haag SM; Hauck EW; Szardening-Kirchner C; Diemer T; Cha ES; Weidner W; Eickelberg O Eur Urol; 2007 Jan; 51(1):255-61. PubMed ID: 16782264 [TBL] [Abstract][Full Text] [Related]
12. [Peyronie's disease and peripheral neuropathies]. Diagne M; Gueye SM; Ba M; Konan PG; Diop AG; Ndiaye MM; Ndiaye IP; Mensah A Dakar Med; 1998; 43(2):234-7. PubMed ID: 10797972 [TBL] [Abstract][Full Text] [Related]
13. Peyronie's disease: current management. Fitkin J; Ho GT Am Fam Physician; 1999 Aug; 60(2):549-52, 554. PubMed ID: 10465229 [TBL] [Abstract][Full Text] [Related]
14. [Historical considerations on La Peyronie's disease. Very little has changed!]. Jolidon C; Zephir D; Ybert G J Urol (Paris); 1984; 90(5):365-6. PubMed ID: 6389715 [TBL] [Abstract][Full Text] [Related]
15. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. Nachtsheim DA; Rearden A J Urol; 1996 Oct; 156(4):1330-4. PubMed ID: 8808864 [TBL] [Abstract][Full Text] [Related]
16. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. Kalsi J; Minhas S; Christopher N; Ralph D BJU Int; 2005 May; 95(7):1029-33. PubMed ID: 15839925 [TBL] [Abstract][Full Text] [Related]